Lippo Beheer

Beheer criteriumcontroles 1/4

De CEO Lippo is Davy Lee, benoemd in Jun2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde HK$ 35.01. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1 jaar en 20.9 jaar.

Belangrijke informatie

Davy Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.00001%
Management gemiddelde ambtstermijn	1yrs
Gemiddelde ambtstermijn bestuur	20.9yrs

Recente managementupdates

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

May 30

Recent updates

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

May 30

CEO

Davy Lee (65 yo)

less than a year

Tenure

Mr. Kwok Fai Lee, also known as Davy, is Executive Director & CEO of Lippo China Resources Limited from June 7, 2024. Mr. Lee had been a Secretary of Lippo Ltd since April 1991 until June 7, 2024. He also...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Brian Riady	Executive Director	1.7yrs	HK$600.00k	geen gegevens
Kwok Fai Lee	Executive Director	less than a year	geen gegevens	0.000010% HK$ 35.0
Shiu Leung Au	Chief Financial Officer	13.3yrs	geen gegevens	geen gegevens
Fun Luk Yuen	Company Secretary	less than a year	geen gegevens	geen gegevens

1.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van 226 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Brian Riady	Executive Director	1.7yrs	HK$600.00k	geen gegevens
Kwok Fai Lee	Executive Director	less than a year	geen gegevens	0.000010% HK$ 35.0
Mochtar Riady	Honorary Chairman	21.6yrs	geen gegevens	geen gegevens
Stephen Riady	Executive Chairman	33.7yrs	HK$15.71m	geen gegevens
Luen Wai Lee	Deputy Chairman	33.7yrs	HK$3.15m	0.21% HK$ 732.2k
Jark Pui Lee	Non-Executive Director	32.3yrs	HK$263.00k	0.000010% HK$ 35.0
Min Yen Goh	Independent Non-Executive Director	1.9yrs	HK$1.13m	geen gegevens
Nim Leung Chan	Non Executive Director	27.5yrs	HK$1.30m	geen gegevens
Ha Kuk Yung	Independent Non Executive Director	20.2yrs	HK$926.00k	geen gegevens
King Fai Tsui	Independent Non-Executive Director	20.2yrs	HK$1.02m	geen gegevens

20.9yrs

Gemiddelde duur

69yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 226 zijn ervaren en ervaren (gemiddelde ambtstermijn van 20.9 jaar).

Lippo Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Lippo Limited Announces Chief Executive Officer Changes, Effective from 7 June 2024

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

Lippo Limited, Annual General Meeting, Jun 06, 2024

Less than half of directors are independent

Lippo Limited Announces Change of Independent Non-Executive Director- and Composition of Board Committees

Less than half of directors are independent

Recent updates

First half 2024 earnings released: HK$0.89 loss per share (vs HK$0.005 profit in 1H 2023)

First half 2024 earnings released: HK$0.89 loss per share (vs HK$0.005 profit in 1H 2023)

Lippo Limited to Report Q2, 2024 Results on Aug 27, 2024

Lippo Limited Announces Chief Executive Officer Changes, Effective from 7 June 2024

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

Lippo Limited, Annual General Meeting, Jun 06, 2024

Full year 2023 earnings released: HK$0.07 loss per share (vs HK$0.25 profit in FY 2022)

Lippo Limited to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is Lippo (HKG:226) A Risky Investment?

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

New minor risk - Earnings quality

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings released: EPS: HK$0.25 (vs HK$1.01 in FY 2021)

Less than half of directors are independent

Lippo Limited Announces Change of Independent Non-Executive Director- and Composition of Board Committees

Less than half of directors are independent

First half 2022 earnings released

First half 2022 earnings released: EPS: HK$0.21 (vs HK$0.24 in 1H 2021)

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022

Lippo Limited to Report First Half, 2022 Results on Aug 30, 2022

Lippo Limited Approves Final Dividend for the Year Ended December 31, 2022

Upcoming dividend of HK$0.04 per share

Less than half of directors are independent

Lippo Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings released: EPS: HK$1.01 (vs HK$2.19 loss in FY 2020)

Lippo Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 29 June 2022

Lippo Limited to Report Fiscal Year 2021 Final Results on Mar 31, 2022

Upcoming dividend of HK$0.03 per share

Lippo Limited Proposes Final Dividend for the Nine Months Ended 31 December 2020

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Zooming in on HKG:226's 4.0% Dividend Yield

Lippo Limited to Report Nine Months, 2021 Results on Mar 30, 2021

How Much Does Lippo's (HKG:226) CEO Make?

Lippo's(HKG:226) Share Price Is Down 50% Over The Past Three Years.

First half 2021 earnings released: HK$1.30 loss per share

New 90-day high: HK$2.48

Is Lippo (HKG:226) A Risky Investment?

First half 2021 earnings released: HK$1.30 loss per share

Tread With Caution Around Lippo Limited's (HKG:226) 3.9% Dividend Yield

Lippo Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$2.04

New 90-day low: HK$2.06

New 90-day low - HK$2.22

Full year earnings released - HK$0.021 loss per share

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd